A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)
Incyte Corporation
Incyte Corporation
The Netherlands Cancer Institute
Celldex Therapeutics
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Massachusetts General Hospital
Fred Hutchinson Cancer Center
GlaxoSmithKline
Vanderbilt University Medical Center
Pfizer
FeRx